MellingMedical to Provide CorneaGen Tissues to Federal Healthcare Facilities
MellingMedical and CorneaGen today announced an agreement that will expand corneal tissue options for physicians in the federal healthcare system, including the Veterans Health Administration.
“More than 250,000 US veterans are currently receiving disability compensation for eye or vision problems,” said Chris Melling, founder and CEO of Melling.Medical noted in the statement, “We are honored to work with CorneaGen to increase the quantity and quality of corneal tissue available for the treatment of veterans potentially suffering from vision loss or impairment due to glaucoma.”
According to a press release from the companies, the agreement will open a channel between federal healthcare facilities and CorneaGen laboratories whose advanced tissue processing methods produce more corneas than any other corneal tissue organization in the United States. The Seattle-based company’s comprehensive corneal transplant tissue portfolio is processed according to standards set by the FDA and the Eye Bank Association of America.
“CorneaGen provides the highest quality tissues, services and donor products to surgeons and their patients while innovating in corneal care,” said Bernie Iliakis, president of CorneaGen in the release. “This partnership with MellingMedical expands our commitment to transforming the lives of those affected by corneal disease by restoring sight, especially U.S. veterans.”